Diagnos Inc. ADK.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · diagnos.com
DIAGNOS Inc. is a Canadian healthcare technology company that uses artificial intelligence for early detection of eye diseases. Its flagship product, the CARA System (Computer Assisted Retina Analysis), is a web-based tool that helps healthcare professionals detect diabetic retinopathy through AI-driven image processing of fundus photography. Founded in 1998 and headquartered in Brossard, Quebec, the company is seeking regulatory approvals in Canada (Health Canada), the United States (FDA), and Saudi Arabia (SFDA).
Key ratios
FreeCashFlowOnSale TTM -56.07
FreeCashFlowOnSale 2025 -35.18
FreeCashFlowOnSale 2024 -12.68
FreeCashFlowOnSale 2023 -3.93
ReturnOnAssets TTM -0.78
ReturnOnAssets 2025 -1.11
ReturnOnAssets 2024 -2.19
ReturnOnAssets 2023 -1.18
ReturnOnEquity TTM -9.24
Recent news
CIRO Trade Resumption - ADK (Diagnos Inc.)
2026-07-27 · CNW
DIAGNOS Receives Health Canada Medical Device Licence for CARA System
2026-07-27 · GlobeNewswire
DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
2026-06-12 · GlobeNewswire
DIAGNOS Announces the Engagement of IBN
2026-01-15 · Yahoo Finance